Oracle Corporation - Deep Financial Research

Background Research#

Business Model and Main Sources of Income#

Oracle Corporation is one of the world's largest enterprise software and IT infrastructure providers, offering a broad portfolio of database software, business applications (ERP, CRM, etc.), and cloud computing services. Oracle's business model has transitioned in recent years from traditional on-premises software licensing to cloud-based services. The company operates in three primary segments:

• Cloud Services and License Support - Recurring revenue from Oracle's cloud SaaS/PaaS/IaaS offerings and ongoing software support/update contracts for on-premise licenses. This is Oracle's largest revenue source (detailed below). Customers pay subscription fees for cloud services or annual support fees for licensed software.

• Cloud License and On-Premise License - One-time fees from sales of new software licenses (for on-premise use or customer-managed cloud) and cloud license deployments. These are upfront revenues recognized when Oracle sells new software licenses to customers (many of whom then also purchase support).

• Hardware - Sales of Oracle's engineered systems, servers, storage appliances, and related hardware support. Oracle's hardware products (like Exadata and Oracle servers) generate revenue both from initial hardware sales and from support contracts.

• Services - Revenue from consulting, implementation, and advanced customer support services to help clients use Oracle products effectively. This includes professional services and training.

Revenue Breakdown: Oracle's income is dominated by its cloud services and license support segment. In fiscal year 2024, Oracle's total revenue was about $53.0 billion, of which roughly 74% came from cloud services and license support subscriptions. The remaining revenue was split among new licenses (~10%), services (~10%), and hardware (~6%). The chart below illustrates Oracle's FY2024 revenue mix:

Oracle FY2024 revenue by segment (total $52.96B). Cloud Services & License Support represents the bulk of Oracle's revenue.

As shown, recurring cloud services & license support revenue was about $39.4B in FY2024 (74.3% of total). Cloud license & on-premise license sales contributed roughly $5.1B (~9.6%). Services revenue was $5.4B (~10.2%), and Hardware revenue was $3.1B (~5.8%). This revenue mix underscores Oracle's dependence on recurring cloud and support contracts, which provide a high-margin, predictable income stream (Oracle's cloud/support gross margins exceed 75%).

Oracle's business model is increasingly cloud-centric: the company not only sells cloud software applications (SaaS) like Fusion ERP and NetSuite, but also rents out cloud infrastructure capacity (OCI - Oracle Cloud Infrastructure) and platform services. These cloud services are delivered from Oracle's data centers and also via partnerships to run Oracle Cloud inside other clouds (e.g. Microsoft Azure). Oracle still monetizes on-premises customers through support contracts and occasional license sales, but growth is driven by cloud adoption. The subscription-based cloud model provides Oracle with recurring revenue and higher lifetime client value, albeit often at the expense of lower upfront fees compared to legacy license sales.

Customers and Units Sold: Oracle serves hundreds of thousands of customers worldwide - businesses of all sizes, governments, and educational institutions. Exact customer counts aren't regularly disclosed, but Oracle's reach is broad across industries (notably financial services, retail, manufacturing, and the public sector). For instance, Oracle's cloud ERP has thousands of customers, and NetSuite (targeted at mid-market firms) had 32,000+ customers as of a few years ago. The company often highlights that all 100 of the Fortune 100 use Oracle in some capacity.

In terms of "units" sold: Oracle doesn't sell physical units for software, but for hardware, it sells engineered systems (e.g. Exadata database machines) - likely a few thousand such systems annually (exact figures are not public). For cloud, Oracle measures adoption in cloud consumption (for IaaS) and number of SaaS users. For example, Oracle's Fusion Cloud ERP had over 10,000 customers as of 2023, and Oracle's cloud database services are used by thousands of organizations (recently expanded via partnerships with Microsoft and Google). While specific counts are proprietary, Oracle's cloud user base and customer count have been growing, evidenced by a 44% jump in Remaining Performance Obligations to $98B by FY2024 (a proxy for contracted future cloud and support revenue).

Short-Term and Long-Term Headwinds & Risks#

Oracle faces several headwinds in both the near term and long term:

• Short-Term / Temporary Factors:

  • Macroeconomic conditions: Broad economic slowdowns or IT spending delays can temporarily soften Oracle's revenue. For example, in times of recession or tight IT budgets, companies may defer software upgrades or cloud migrations, impacting Oracle's short-term sales growth. Foreign exchange fluctuations are another short-term factor - a strong U.S. dollar can reduce reported revenue growth in USD (Oracle noted 2024 revenue was up 6% in USD and constant currency, implying FX headwinds).

  • Political & Regulatory: Geopolitical events (trade restrictions, sanctions) or regulatory delays can postpone government or international deals. For instance, government procurement slowdowns or uncertainty around U.S.-China trade relations could temporarily impact Oracle's hardware exports or cloud region expansion in certain countries. These are typically transient and resolve over time.

  • Cloud Capacity & Data Center Build-Out: In the near term, Oracle's cloud growth could be constrained by data center capacity. Management noted that in FY2024 some cloud demand outpaced available OCI infrastructure, and they are racing to build new data centers. This is a good problem (demand > supply), but in the short run, if OCI cannot provision capacity fast enough, revenue might be deferred. Oracle expects this to ease as new capacity comes online in FY2025.

  • Integration of Acquisitions: Oracle's recent acquisitions (e.g. Cerner in 2022 for healthcare IT) present short-term execution risk. Integrating acquired companies can temporarily distract management and incur restructuring costs. Notably, Oracle's FY2022 net income was reduced by acquisition-related expenses from the Cerner deal. Over a few quarters, these integration issues usually stabilize.

• Long-Term / Structural Factors:

  • Cloud Competition: Oracle's biggest long-term challenge is competing against top cloud providers (Amazon AWS, Microsoft Azure, Google Cloud) in infrastructure and against SaaS specialists (like Salesforce, Workday) in applications. Oracle was a late entrant to cloud and must fight for market share. The risk is that despite recent gains, Oracle could permanently lose database or application workloads to competitors' cloud platforms. For example, AWS and Azure offer database services that threaten Oracle's core database franchise. Intense competition could pressure Oracle's growth and margins in the long run if not managed.

  • Technology Transitions: The IT industry evolves rapidly (e.g. rise of open-source databases, AI-driven automation). Oracle faces the risk of technological disruption. Open-source databases (MySQL, PostgreSQL - though Oracle owns MySQL) and cloud-native databases have eroded the dominance of Oracle's flagship Database in some scenarios. Additionally, the shift to AI and machine learning workloads- Oracle is adapting by offering AI cloud services, but failure to lead in new tech paradigms could be a long-term headwind.

  • Permanent On-Premises Decline: Oracle still derives significant revenue from legacy on-premise license support (~$19.6B in FY2024). This stream could permanently decline as customers migrate to cloud alternatives (some not Oracle's). Oracle needs to successfully transition these customers to Oracle Cloud to avoid a long-term attrition of its installed base. A related risk is customer consolidation and saturation - many large enterprises already run Oracle, so growth must come from expanding cloud services usage or taking share from competitors.

  • Economic & Political Regime Changes: While macro effects can be short-term, there are potential lasting effects from broad changes like deglobalization or major regulatory shifts. For instance, increased data sovereignty laws (requiring data to be stored locally) could raise costs for Oracle's global cloud operations long-term. Similarly, if U.S.-China relations worsen significantly, Oracle's business in China (which historically contributed a few percent of revenue) could be permanently constrained.

  • Leadership and Cultural Factors: Larry Ellison (Oracle's co-founder, CTO and former CEO) remains a driving force in Oracle's strategy. At 79 years old, Ellison's eventual transition could pose long-term uncertainties. Oracle's culture and vision have been heavily influenced by Ellison - any future leadership change is a longer-term consideration. However, CEO Safra Catz has been with Oracle ~24 years and provides continuity.

In summary, Oracle's short-term risks relate to economic cycles and execution (cloud capacity, acquisition integration) which could temporarily slow results for a few quarters. Its long-term headwinds center on structural industry shifts and competitive dynamics that could permanently impact the business if Oracle fails to adapt (cloud competition, technological disruption, declining legacy business). So far, Oracle has shown resilience by pivoting to cloud and leveraging its entrenched enterprise customer base, but these strategic challenges will persist.

Cost Structure: Fixed vs. Variable Costs#

Oracle's cost structure combines high fixed costs (for product development and sales) with variable costs (especially to deliver cloud services). Key cost components include:

• Research & Development (R&D): R&D is a largely fixed cost. Oracle spent $8.9 billion on R&D in FY2024 (about 17% of revenue). This includes software development, engineering salaries, and product enhancements. R&D doesn't fluctuate directly with sales in the short term - Oracle maintains steady investment to improve its database, applications, and cloud platform. Over time, R&D has grown (it was $7.2B in FY2022, $8.6B in FY2023) as Oracle invests in cloud and emerging tech. In economic downturns Oracle might slow hiring but generally R&D is fixed and critical for long-term competitiveness.

• Sales and Marketing (S&M): These include salesforce salaries, commissions (variable portion), and marketing programs. In FY2024, S&M expense was $8.27B. A chunk of S&M is fixed (base salaries, marketing campaigns) but there's a variable component - e.g. sales commissions and bonuses scale with bookings. Oracle noted S&M expense actually decreased slightly in 2024 (from $8.83B to $8.27B) partly due to lower headcount and sales-related expenses. In tougher economic conditions, Oracle can trim variable sales compensation or discretionary marketing, making S&M semi-variable. However, cutting too deeply could hurt future sales, so Oracle balances cost control with continued customer engagement.

• Cloud Infrastructure & Support Costs (Cost of Cloud Services): Operating Oracle's cloud (data center facilities, servers, network, energy, and cloud support staff) is a variable cost that scales with usage and capacity. In FY2024, cloud services and license support expense was $9.43B. As cloud revenues grow, Oracle must spend more on infrastructure and personnel to serve customers - but there are economies of scale (gross margin ~76% in this segment). This cost is partly fixed (maintaining data centers ready for peak loads) and partly variable (e.g. electricity, third-party cloud hosting, usage-based components). In downturns, if cloud usage growth slows, these costs would also grow more slowly. Oracle's challenge is to optimize cloud capacity - unused capacity is a fixed cost drag, whereas fully utilized infrastructure improves margins.

• Hardware Manufacturing & Support Costs: These vary with hardware sales volume. Oracle's hardware cost of goods was $0.891B in FY2024 (on $3.07B hardware revenue). This includes component costs and assembly (Oracle outsources hardware manufacturing). It's mostly variable per unit, though Oracle has some fixed overhead in managing the hardware business. As hardware revenue has been declining, Oracle has reduced these costs (FY2024 hardware COGS fell 14% YoY) to maintain margins. In a given quarter, if hardware sales drop, Oracle's material costs drop too, but not perfectly - there are fixed support and supply chain expenses in this segment.

• General & Administrative (G&A): G&A was $1.55B in FY2024 - this covers corporate overhead, legal, finance. It behaves as fixed cost (relatively stable year to year). Oracle did show a slight decrease in G&A from $1.58B to $1.55B in 2024, indicating some cost discipline or one-time savings. G&A might be scaled back modestly in lean times (e.g. fewer contractors, travel), but core G&A is needed to run the business and thus largely fixed.

• Capital Expenditures (CapEx): While not an operating expense, it's worth noting Oracle's CapEx has risen due to cloud - building data centers is capital-intensive (servers, facilities). CapEx peaked around $4 billion in FY2022 as Oracle invested in cloud capacity and acquired Cerner data centers. CapEx is a fixed investment that doesn't vary short-term with revenue, but Oracle can adjust future CapEx plans depending on expected demand (e.g. accelerate or delay data center construction). CapEx affects cost per unit in cloud (depreciation per server). Oracle's depreciation expense flows into cost of cloud services over hardware lifetimes, so if CapEx is underutilized, cost per unit of cloud rises. Oracle's strategy is to grow cloud revenue to absorb these fixed infrastructure costs.

Cost Per Unit and Trends: Oracle's cost per revenue dollar has generally improved in stable periods and worsened temporarily during transitions. For instance, as cloud revenue grows, gross margin improves (spreading fixed data center costs). Oracle's cloud gross margin expanded as OCI scale increased and legacy support (very high margin) remains large. However, in FY2022 Oracle's net margin dropped due to integration costs of Cerner (a lower-margin business initially) - essentially a temporary hit. In economic downturns, Oracle's margins may compress slightly if revenue growth stalls while fixed costs like R&D and cloud infrastructure continue. Oracle tends to prioritize sustaining R&D and cloud capacity for long-term competitiveness, even if it means short-term margin pressure. Conversely, in boom times or high growth periods, fixed costs are leveraged and margins expand. Historically, Oracle has very high operating margins (often ~40% non-GAAP). In FY2024, GAAP operating margin was ~29% (lower due to Cerner amortization and stock comp), but excluding those it was ~44%. This underscores Oracle's high fixed-cost, high-margin model: once expenses are covered, additional sales heavily contribute to profit. Over the past decade, Oracle's operating expenses grew much slower than revenue, reflecting efficiency and cost discipline. For example, sales and marketing in 2024 was slightly lower than 2019 even though revenues were higher - Oracle trimmed sales costs as much of its revenue comes from renewals (lower cost than new sales). During economic stress (like 2020's pandemic), Oracle managed to keep R&D and S&M roughly flat, protecting profitability, and in fact operating income still grew. In summary, fixed costs (R&D, much of S&M, cloud infrastructure depreciation) are significant and require Oracle to maintain a large revenue base; variable costs (sales commissions, cloud energy usage, hardware components) provide some flexibility to scale down if demand falls. Oracle's largest expenses - R&D and cloud ops - tend to persist across economic cycles, reflecting a commitment to innovation and service delivery even in downturns.

Management Team and Governance#

Current Executive Leadership: Oracle is led by Safra A. Catz (CEO) and Lawrence J. "Larry" Ellison (CTO and Chairman). Safra Catz has been with Oracle since 1999 and became CEO in 2014 (initially co-CEO, sole CEO since 2019). She is known for her financial acumen and has overseen Oracle's profitability and acquisition integration for years. Larry Ellison co-founded Oracle in 1977 and served as CEO until 2014; he remains deeply involved as Chief Technology Officer (driving product strategy) and as Chairman of the Board. Ellison (age 79) is the visionary behind Oracle's database and cloud push, and his continued role provides technological direction and continuity. Other key executives include: Edward Screven (Chief Corporate Architect), who guides Oracle's technology roadmap, Juan Loaiza (EVP, Oracle Database Technologies), and Clay Magouyrk (EVP, Oracle Cloud Infrastructure) - all long-tenured leaders responsible for Oracle's core product areas. Oracle's executive team is notably stable; many have decades at the company, which has helped maintain strategic consistency.

Board of Directors: Oracle's Board is chaired by Larry Ellison and includes 14 other directors, a mix of industry veterans and independent members. Notable board members are Jeffrey O. Henley (Vice Chairman) - Oracle's former CFO, on the board since 1991; Michael Boskin (Stanford economist, on board since 1994); Bruce Chizen (former Adobe CEO); Leon Panetta (former U.S. Defense Secretary and CIA Director); and several others with diverse backgrounds in technology, finance, and government (Naomi Seligman, George Conrades, etc.). The board skews older and has faced some criticism in the past for long tenures. However, it provides experience and oversight. Importantly, Safra Catz is also on the board, and Mark Hurd was a director until his passing in 2019 (the AdvisoryCloud reference is outdated). Oracle's board is generally considered management-friendly (Ellison's sizable ownership influences this). They have approved Oracle's aggressive share buybacks and acquisition strategy historically. The board's compensation committee has drawn shareholder ire in the past for large executive pay packages (Ellison's security costs, stock option grants to CEOs), which ties into governance concerns discussed below.

Historical Leadership and Culture: Oracle's leadership under Ellison has been famously competitive and bold. The company grew through a combination of technological innovation and aggressive acquisition of competitors. A historical executive of note is Bob Miner (Oracle co-founder, lead architect of Oracle's database; he passed away in 1994) - while not on the current team, his engineering ethos set early technical direction. Another is Jeffrey O. Henley, Oracle's CFO from 1991-2004, who helped shape Oracle's financial strategy and remains as Vice Chairman. In the 2000s, Oracle's second-in-command was Charles Phillips (President) and then Mark Hurd (former HP CEO) who joined as co-CEO in 2014. Hurd was known for operational excellence and sales rigor; his tenure (2014-2019) alongside Catz was marked by a smooth transition as Ellison stepped back from day-to-day management. After Hurd's death, Safra Catz has solely led as CEO. The continuity of having long-time insiders (Catz, Ellison) at the helm has meant Oracle's strategy (focus on database dominance, aggressive sales, cloud shift) has been consistently executed. Oracle's culture has often been described as highly results-driven and sometimes combative in the marketplace (reflecting Ellison's personality). While that culture successfully built an enterprise software giant, it has had downsides (e.g. some customer dissatisfaction with aggressive sales tactics in the past). Recently, Oracle's culture has been evolving to be more cloud-customer-centric, though it remains very much performance-focused.

Management Credibility and Track Record: Oracle's management has a mixed but generally positive track record with investors:

• Following Through on Promises: In the past, Oracle sometimes over-promised on "cloud" growth when transitioning its reporting. Notably in 2018, Oracle stopped separately disclosing cloud revenues and folded them into broader categories, which some analysts viewed as a lack of transparency when cloud growth appeared to slow. This raised questions about management credibility at that time. However, in recent years Safra Catz tends to give conservative guidance and often meets or beats it. For example, Oracle projected mid-single digit revenue growth for FY2024 and delivered 6% (constant currency). On major strategic shifts (like building a Gen2 Cloud or acquiring Cerner to enter healthcare IT), Oracle has executed steadily - cloud revenue is now accelerating (up 50%+ in IaaS for Q4 FY2025), and the Cerner unit (Oracle Health) is being integrated with an eye toward long-term growth despite short-term margin impact. Overall, management has delivered on turning Oracle into a cloud contender, albeit later than some rivals.

• Transparency and Problem Disclosure: Oracle's management provides substantial detail on financials but can be opaque on certain metrics (like cloud segment profitability). They generally do not "hide" problems outright, but in the 2010s Oracle was criticized for not breaking out cloud vs on-prem revenue which masked the slow start of Oracle's cloud business. More recently, Oracle has been upfront about challenges - e.g. Safra Catz acknowledged that legacy license sales were declining and cloud was cannibalizing some of that, which is a transition Oracle must navigate. On earnings calls, Catz is known for being direct and factual, though often tight-lipped beyond guidance and prepared remarks. She tends not to sugarcoat results - for instance, if currency hurt results or an acquisition trimmed margins, she'll state it. However, Oracle's communication style is generally less candid than some peers (they prefer prepared scripts to spontaneous Q&A depth). The management doesn't often volunteer negative news, but required disclosures (like a revenue miss or large loss contracts) are made. Importantly, no major scandalsregarding financial reporting have occurred since Oracle's early history (in the 1990s Oracle had a one-time accounting issue with revenue recognition, long resolved). Investors' trust in Oracle management is decent, though some have been skeptical of Oracle's ability to innovate in cloud - something Ellison and Catz have worked to prove through results.

• Analyst Engagement: On earnings calls, Safra Catz and Larry Ellison both speak. Catz handles financials; Ellison often interjects with product commentary. Ellison can be feisty - in past calls he has openly criticized competitors or dismisses certain analyst concerns. For example, when asked about cloud competition, Ellison has been known to confidently claim Oracle will surpass rivals in database cloud, sometimes with bold statements. Safra Catz, by contrast, answers analysts' questions in a measured, if somewhat guarded, manner. If an analyst asks something she views as off-base, she often reiterates Oracle's official stance rather than provide new detail. Analysts have noted that Oracle's calls are less "open" than some peers - management sticks to key points. Nonetheless, they do address major questions (such as Cerner growth rates, cloud capex needs, etc.) albeit often without extensive elaboration.

Integrity and Shareholder Alignment: There have been occasional concerns about Oracle's governance - particularly executive compensation. Larry Ellison famously took $1 salary for years but received huge stock option grants and Oracle covers his personal security costs (over $1.5M/year). Safra Catz's pay has also been very high (including large multi-year stock options). In 2019, Oracle's "say on pay" vote barely passed with ~53% approval, meaning nearly half of shareholders objected to the pay packages. Proxy advisors ISS and Glass Lewis have flagged Oracle for potential governance issues like lack of an independent board chair and outsized executive awards. Some institutional investors have questioned management's alignment given these pay issues. However, it's also true that Ellison owns ~40% of Oracle, an enormous personal stake worth tens of billions, which arguably aligns his interests with all shareholders (Oracle's share price performance directly impacts Ellison's net worth significantly). Safra Catz, in contrast, owns only ~0.03% (about 1.1 million shares as of 2025, after selling stock over years). Her wealth is still largely tied to Oracle's success through stock grants, but she has periodically sold shares (including a ~$200M sale in June 2025). Those sales follow pre-set plans and often involve exercising options, but heavy insider selling can cause investor unease. Notably, Ellison himself has occasionally sold small portions of stock, usually to fund personal ventures (e.g. his purchase of Hawaiian island Lanai), but he retains the vast majority. There haven't been allegations of wrongdoing by Oracle's management in recent memory; the questions are more about shareholder friendliness (e.g. returning cash, avoiding entrenchment).

In terms of longevity, Safra Catz has been CEO for 9 years (in Oracle's C-suite for over two decades) and is well-regarded for operational and financial execution. Larry Ellison's relentless focus on winning (sometimes at the expense of warm customer relations) defined Oracle's culture, but he's mellowed somewhat in public presentations, now emphasizing Oracle's technology strengths. Management's credibility improved recently as Oracle's cloud momentum picked up, validating their strategy. There were skeptics who doubted Oracle's cloud pivot; the strong FY2023-FY2025 cloud numbers have answered some of those doubts. As a result, Oracle's stock hit all-time highs in 2023-2025, reflecting renewed investor confidence in management's strategic execution.

Value Alignment (Skin in the Game): Oracle's top leadership has significant equity interests. Larry Ellison owns roughly 1.145 billion Oracle shares (≈40% of shares outstanding) - an extraordinarily high insider ownership for a $300B+ company. This stake, worth over $100 billion, means Ellison's wealth is heavily tied to Oracle's stock performance, arguably aligning his interests with shareholders. He benefits far more from Oracle's market cap growth than from any salary (his annual salary is trivial, though he does get stock options and perks). Safra Catz, while not an owner on Ellison's scale, has accumulated shares over years - but she tends to exercise options and sell stock regularly. As of 2025 she directly owned ~1.12 million shares (worth ~$250M at current prices) after a recent sale. She also holds additional vested and unvested options. Her net worth thus does depend on Oracle's share price, and Oracle has often structured CEO compensation with large performance stock units (PSUs) that only pay if stock targets are met. For example, in 2018 Oracle granted Catz and Hurd multi-year performance stock options requiring Oracle's stock to outperform the market by certain thresholds - showing an attempt at alignment (though some shareholders still opposed the scale of the grant). Other directors and executives own comparatively small stakes (outside Ellison).

A point to note is Ellison's stake could theoretically create a conflict: as such a large shareholder, he can heavily influence votes (which can deter activist investors and certain governance changes). But from a value perspective, Ellison has an interest in Oracle's long-term success and has often preached that he manages Oracle for the long run, not short-term stock pops.

Insider Buying/Selling in Declines: Insiders at Oracle (aside from Ellison) generally sell on strength rather than buy on dips. We have not seen Safra Catz or other top execs make open-market purchases during stock drops. Instead, they tend to exercise options and sell as part of diversification or pre-arranged plans. For example, in early 2022 when Oracle stock dipped after the Cerner acquisition announcement, we did not see public filings of Safra or others buying stock; rather, Safra continued selling some shares that year as per her trading plan. Ellison also has not really bought Oracle stock on the open market in recent memory - but he also hasn't sold large portions (only small periodic sales). Essentially, Ellison's huge existing stake serves as his "skin in the game," whereas other execs are not known for opportunistic buying during short-term declines. This might raise a slight concern about confidence, but it's also common for executives with large option grants to monetize some portion.

Capital Allocation and Shareholder Meetings: Oracle's management has shown strong shareholder-return tendencies via massive share buybacks and regular (and increasing) dividends. Over the last decade, Oracle repurchased an astonishing amount of stock - its share count dropped from ~4.6 billion in 2014 to ~2.8 billion by 2024. These buybacks (over $70 billion worth in 10 years) returned capital to shareholders and boosted EPS, aligning with value investors' interests. Safra Catz, as a former investment banker, is very focused on efficient capital use; she once quipped that Oracle's goal was to "shrink the float" aggressively when the stock was undervalued. Indeed, Oracle repurchased shares heavily especially in the 2017-2020 period when the stock traded at lower multiples (e.g. ~$40-50). This indicates management believed the stock was a good investment then - an alignment with long-term shareholders. In recent years, buybacks slowed (only ~$0.9B total in FY2024, mainly to offset stock compensation) as Oracle used cash for Cerner and deleveraging. But Oracle announced a new buyback authorization of $10B in 2022 after the acquisition, and by Q4 2025 the board authorized a further $20B buyback, signaling continued commitment to returning cash. The dividend was initiated in 2009 and has grown consistently (from $0.05/quarter in 2009 to now $0.50/quarter in 2025). This steady dividend growth (14% CAGR over 10 years) shows alignment with shareholders seeking income. The latest raise in June 2023 (from $0.32 to $0.40) and again in June 2025 (to $0.50) demonstrates management/shareholder alignment in sharing profits.

In shareholder meetings and votes, Ellison's influence dominates (he controls ~40% voting power). This means shareholder proposals not supported by Ellison/board typically fail. For example, proposals for an independent board chair or enhanced pay equity reporting have been regularly voted down - likely because Ellison (and allied insiders) vote against them. On the advisory "Say on Pay," as mentioned, 2019's vote was low. The board responded by slightly modifying compensation structure, and by 2021 say-on-pay support rose to 78%. Top institutional shareholders (Vanguard ~5.7%, BlackRock ~5.2%) generally vote with management on most issues except extreme cases. In Oracle's case, in 2019 both Vanguard and BlackRock did vote against the say-on-pay (per reports of low support) - essentially sending a message on pay practices. Oracle's management took note but did not drastically cut pay; they framed high pay as necessary to retain top talent. This episode shows some tension but ultimately management's large ownership can override external dissent.

Overall Management Assessment: Oracle's management team is highly experienced and deeply invested (especially Ellison) in the company's success. They have navigated Oracle through major industry transitions (mainframe to client-server, to internet, to cloud) and maintained Oracle's profitability. There have been concerns about governance (e.g. board independence, executive pay), but no evidence of malfeasance. Shareholders have benefited from Oracle's substantial buybacks and dividends, though some might prefer more conservative pay. The presence of Ellison as both a major owner and CTO ensures continuity of vision (database and applications focus, integrated tech stack strategy). Safra Catz provides financial discipline - Oracle has consistently high margins and cash flows under her watch. One could argue management was late to cloud, but once convinced, they redirected the company aggressively (even accepting short-term margin hits to build cloud capacity and acquire cloud capabilities like NetSuite and Cerner). Their recent execution suggests they are meeting the challenges, as seen in accelerating cloud revenues and upbeat FY2025 guidance (expecting double-digit growth). Going forward, investors will watch how Oracle's management capitalizes on new trends (AI) and continues integrating acquisitions to sustain growth. The significant insider ownership (Ellison) and long tenures indicate management's incentives are largely aligned with long-term value creation, albeit with the caveat of Ellison's outsized control possibly stifling certain governance changes that other shareholders might favor.

Top Shareholders and Shareholder Votes#

Oracle's ownership is concentrated. Larry Ellison is by far the largest shareholder with roughly 1.145 billion shares (about 40.8% of the company). This stake gives Ellison effective veto power on any shareholder resolutions and board elections. The next largest holders are the big index fund firms: Vanguard Group owns ~146.5 million shares (~5.2%), BlackRock about 160.9 million (5.7%), and State Street around 3% (these figures can fluctuate slightly each quarter). Other notable holders include Berkshire Hathaway briefly in 2018 (Buffett bought $2B stake, ~1% of Oracle, then sold within a quarter) - as of now Berkshire has no Oracle position. Institutional ownership overall is high (over 50% of shares, excluding Ellison), meaning most non-Ellison shares are held by mutual funds, ETFs, pensions, etc. These institutions typically vote in line with proxy advisor recommendations on governance issues.

At Oracle's shareholder meetings, all board-nominated directors are routinely elected (Ellison's votes ensure that). Shareholder proposals occasionally appear - in recent years, proposals have included: (1) a request for an independent board chair (separate Chair/CEO - essentially asking Ellison to step down as Chair), (2) a pay equity report (asking Oracle to report on gender pay gap), and (3) a proposal to lower the threshold for shareholders to call special meetings or act by written consent. These kinds of proposals have generally not passed at Oracle. For example, proposals to require an independent chairman have been defeated - likely because Ellison's 40% vote plus the board's recommendations against it sway the outcome. The top institutional holders (Vanguard, BlackRock, State Street) often support certain governance reforms across their portfolios - but even if all of them supported a proposal, Ellison's stake can outvote them. In 2020, a shareholder proposal for a gender pay gap report at Oracle received only ~32% support (despite such proposals sometimes getting higher support elsewhere), indicating that large holders did not universally back it or Ellison's block decided it.

Voting Tendencies of Top Shareholders:

• Ellison: Votes with management (himself) on all issues. Essentially, his stance = management stance. He has voted down proposals that would diminish his control (like independent chair).

• Vanguard & BlackRock: These firms have published general proxy voting guidelines. Both typically favor combined CEO/Chair roles only if a strong lead independent director is present (Oracle does have a lead independent director, Dr. Michael Boskin). They sometimes vote for an independent chair in cases of governance concern - it's not public exactly how they voted at Oracle, but the repeated failure of that proposal suggests they likely sided with management or abstained. On executive pay (say-on-pay), in 2019 Vanguard and BlackRock didvote against Oracle's pay package (as evidenced by only ~53% approval, meaning many institutional votes against). Since then, Oracle's say-on-pay approval improved (78% in 2024's meeting), implying the top shareholders became more comfortable (perhaps after Oracle engaged with them and tweaked some pay practices). On shareholder rights (written consent, special meetings), large institutions often support reasonable measures but also defer to board's reasoning. Oracle's board has argued its existing provisions are adequate, and such proposals haven't passed (in 2024, written consent proposals at many firms got ~30-40% support on average, likely similar at Oracle). So Vanguard/BlackRock may have split or been swayed by management arguments in Oracle's case.

• Other Large Holders: State Street tends to vote in line with governance best practices but is also management-friendly. T. Rowe Price, Fidelity, etc. (active managers who hold Oracle) have varied stances but usually focus on financial performance. Given Oracle's stock did well in recent years, active managers were likely supportive of management in votes (since no activist campaign or value destruction scenario is occurring).

Key Topics and Stands: The top shareholders' main "votes of significance" in Oracle's recent history were on executive compensation. Say-on-Pay votes: In 2017 and 2018, Oracle's say-on-pay got unusually low support (for example, 2017 had only ~54% support, 2018 about the same). This reflected institutions being unhappy with huge stock option grants to Ellison, Catz, and Hurd without performance conditions. In 2019, facing a likely defeat, Oracle added performance conditions to a new mega-grant for Catz/Hurd and did extensive outreach; even so, only 53% approved. The opposition came from big institutional investors (Vanguard, BlackRock, CalPERS, etc.) who publicly criticized Oracle's pay practice (CalPERS withheld support for many Oracle directors too that year). By 2021 and 2022, say-on-pay support was up around 85-95%, meaning most top investors were satisfied after Oracle made some changes (e.g. Oracle did not give Ellison new stock options in those years and reduced some perks). Thus, top shareholders effectively pressured Oracle's board to moderate pay, and the board responded enough to placate them (though Oracle still pays top execs richly).

Another significant topic is Oracle's acquisitions and stock issuance. The Cerner acquisition in 2022 was Oracle's largest ever ($28B). It was financed mostly by debt rather than stock, so no shareholder vote was needed (only target shareholders voted). But top shareholders generally supported Oracle's M&A strategy historically, as it drove growth. The only concern was if Oracle were to issue a lot of stock (dilution) for deals - which they usually haven't (they prefer using cash/debt). Indeed, after Cerner, Oracle's share count increased slightly from 2.766B to 2.823B shares (issuing some equity to a trust for Cerner holders), but that ~2% dilution was minor relative to long-term buybacks. Shareholders seem content as long as Oracle's acquisitions eventually bolster earnings.

In annual meetings, routine proposals (election of directors, ratification of auditors, etc.) easily pass. The board of directors elections: Vanguard, BlackRock, etc., have policies to vote against certain directors if, say, they attend <75% of meetings or if there are persistent governance failings. In Oracle's case, despite concerns, no director election has been lost or even close. However, some big funds did withhold votes for some directors in past years as a protest (e.g. the compensation committee members). For instance, in 2019 CalPERS and others voted against director Bruce Chizen (Compensation Committee chair) - he still was re-elected, but with a relatively lower margin. That served as a signal. Oracle's board took note and adjusted pay practices slightly thereafter.

Majority Voting vs Ellison Control: Because Ellison controls ~40%, a simple majority (50%+) of non-insider shares could all vote against something and still lose if Ellison votes for it. To effect change opposed by management, an overwhelming supermajority of outside shareholders would be needed. So far, we haven't seen that level of dissent on any item (even the 2019 say-on-pay got ~47% against, which is significant but not enough when combined with Ellison's yes votes). So effectively, top shareholders often engage behind the scenes with Oracle (through investor relations and governance meetings) rather than mounting public proxy fights that they'd likely lose. By 2025, relations seem stable: Oracle's stock is up strongly, the dividend is increased, and governance issues are not front-page because performance is good. Vanguard and BlackRock's main focus lately has been on ESG issues (like climate disclosure, diversity). Oracle has improved some disclosures (e.g. published sustainability reports, workforce diversity data) - moves likely influenced by large institutional expectations. At the 2022 meeting, a shareholder proposal for an "EEO-1 report" (workforce diversity) got maybe ~40% support - Oracle subsequently published that data voluntarily. This suggests Oracle will yield on some non-core issues if enough shareholders signal interest.

In summary, Oracle's top shareholders (outside Ellison) exert influence mainly through advisory votes and engagement, rather than through decisive votes in meetings (since Ellison's block is controlling). They have pushed for better alignment on pay and transparency, and Oracle's management did make partial concessions. All top institutional holders appear generally supportive of Oracle's strategy - no activist investor campaigns exist, which implies satisfaction with the direction and returns. Oracle's strong recent financial results have likely eased any governance tensions, as investors often give more leeway to management when the share price is performing well.

Share Buyback Program (Current vs 10-Year History)#

Oracle has been a prolific repurchaser of its shares. Over the past 10 years, Oracle spent on the order of $100 billion on share buybacks, reducing its shares outstanding by nearly 45%. This is one of the largest buyback programs among tech companies. The strategy has been to use Oracle's prodigious free cash flow and borrowed funds (when interest rates were low) to retire shares, boosting EPS and returning cash to shareholders.

Historical Buybacks (2013-2022): In the early 2010s, Oracle's share count was around 4.5-5.1 billion. Oracle initiated large repurchases around 2013-2014. For example, in FY2014 Oracle bought back ~$10 billion in stock (reducing the share count from ~4.6B to 4.4B). The pace accelerated: during FY2017-FY2019, Oracle sometimes repurchased $10B+ per year - notably in FY2018 Oracle did an aggressive buyback funded partly by new debt issuance (taking advantage of the 2017 tax reform that allowed repatriating overseas cash cheaply). By May 2019, shares outstanding were down to ~3.73B, a dramatic decline. Oracle continued buybacks in 2019 (e.g. a large ~$12B accelerated buyback in Q2 2019) such that by May 2021, share count was ~3.02B. This is a ~35% drop in shares in just 7 years - significantly enhancing each remaining share's claim on earnings.

Oracle's buybacks slowed after 2019 for a couple reasons: (a) the stock price rose substantially (reducing the attractiveness of buybacks vs other uses), and (b) Oracle took on debt to finance buybacks and had to manage its balance sheet. In the decade prior, Oracle's net debt was low, but by 2020 after big buybacks, Oracle had net debt of $20B. Still, in FY2020-FY2021 Oracle continued moderate repurchases ($15B across those two years).

Current Buyback Plan: Oracle paused large repurchases in FY2022 due to the Cerner acquisition. In June 2022, Oracle issued $15B in new debt for the Cerner deal and understandably curtailed buybacks to focus on debt repayment. As a result, in FY2023 and FY2024, Oracle's buybacks were minimal - primarily offsetting employee stock issuance. For instance, in FY2024 Oracle repurchased only about $0.4B net (they bought back ~$1.1B but also issued ~$0.7B to employees). The share count actually ticked up slightly in FY2023 due to shares issued for the Cerner acquisition and stock compensation, ending a long streak of decline.

However, as of FY2025, Oracle signaled a return to buybacks. In December 2022 (FY2023), Oracle's Board authorized a new $10 billion repurchase program. By March 2023, Oracle used some of it, and in June 2023 Oracle still had ~$8B authorization left. The board in June 2023 then added another $20B authorization, bringing available buyback firepower to about $28B. This coincided with Oracle's stock reaching ~all-time highs (above $120 in mid-2023). Interestingly, Oracle did not rush to execute that authorization immediately - likely because they are balancing debt reduction and cash needs. Through the first half of FY2025, Oracle's 10-Q shows only modest buyback activity (e.g. ~$150M per quarter). This indicates management is being patient - possibly saving the authorization to use opportunistically if the stock weakens or once leverage is reduced further.

Comparison to Former 10 Years: In the former decade (2013-2022), Oracle's average annual buyback yield was around 5-6%, meaning it repurchased about 5-6% of its shares each year on average - exceptionally high. Some years it was much higher (e.g. ~9% in 2018). In contrast, the current pace (2023-2024) has been negligible (<<1% of shares). Essentially, Oracle took a breather from buybacks due to the Cerner acquisition. Now with the new authorizations, we can expect the pace to pick up again. If Oracle uses the $28B authorization fully over say 2-3 years, that could repurchase ~8-10% of shares at current market prices - a significant tailwind to EPS. Safra Catz has stated that once debt is paid down to target levels, any surplus cash will go to buybacks. Oracle's operating cash flow is ~$20B/year, dividend uses ~$6B, CapEx ~$2-3B; that leaves potentially >$10B/year for either debt paydown or buybacks. As interest rates on their new debt are in the ~3.8-4.3% range (from 2022 bond issues), paying those down versus buying stock which has an earnings yield of ~4% (P/E ~25) is roughly breakeven financially - so they can do a mix.

Impact on Shares Outstanding: Over 2014-2019, shares fell by ~15 million per quarter on average. In 2020-2022, it slowed to ~5 million per quarter, and in 2023 it was flat-to-up due to Cerner stock issuance. In 2024, share count was about 2.823B. If Oracle resumes buybacks aggressively, we might see share count drop under 2.5B in a few years. This magnifies per-share metrics and shows management's continued shareholder-friendly stance.

It's worth noting that Ellison benefits enormously from buybacks - his ownership % rose from ~25% in 2010 to ~40% now largely because Oracle bought out other shareholders while he held his stake. Some governance critics say Oracle's buybacks consolidated Ellison's control. But all shareholders who remained saw their stake grow proportionally. Many value investors have applauded Oracle's buybacks, especially when the stock was undervalued in the $40s and $50s a few years ago. Now that the stock is ~$100+, one could question if buybacks are as accretive. However, Oracle's management clearly still sees them as a good use of capital given the large new authorization - implying they believe Oracle's growth prospects make the stock a worthy investment of cash (or simply they have excess cash with no better alternative uses).

In summary, Oracle's current buyback plan is to resume significant repurchases after a hiatus, facilitated by strong cash flows and moderated capex. The former 10-year period saw one of the tech industry's most aggressive buyback campaigns, shrinking the float dramatically. Moving forward, Oracle is likely to continue repurchasing shares, albeit perhaps not quite at the frenetic pace of the late 2010s (unless the stock price dips and they seize the opportunity). The combination of dividends and buybacks should remain a core component of Oracle's capital allocation, underscoring management's confidence in Oracle's long-term business (they're effectively betting on themselves by buying stock) and commitment to returning value to shareholders.

Value Investors' Buy/Sell History in Oracle Stock#

Oracle's stock has been of interest to several prominent value investors over time, though not always with long holding periods. Perhaps the most notable episode was Warren Buffett's Berkshire Hathaway buying a stake in Oracle in late 2018. Berkshire disclosed in Q3 2018 that it purchased ~41 million Oracle shares (about a $2.1 billion position at ~$50/share average). This represented roughly 1.2% of Oracle's shares. However, in Q4 2018, Berkshire abruptly sold the entire stake. Warren Buffett later explained he didn't fully understand Oracle's cloud business prospects and decided to exit. Berkshire likely sold around the same price (Oracle's stock was roughly flat over that span, oscillating $45-53). Thus, Buffett's average buy price was around ~$50 and sell price similar - he basically broke even and missed out on Oracle's subsequent run-up (the stock is ~$100+ as of 2025). Buffett's quick flip (just one quarter) was uncharacteristic, and he publicly said Oracle's business was too hard to predict in the long run (he compared it to his mistaken IBM investment). This shows that even value legends can misjudge tech transitions; Buffett exited too early from today's perspective, as Oracle's cloud strategy gained traction after 2018. Berkshire hasn't re-entered Oracle since.

Another well-known value investor, Seth Klarman's Baupost Group, had Oracle in the past. Baupost bought Oracle shares around 2010 when the stock was relatively cheap (P/E in low teens). Baupost's average cost then might have been in the $20s-$30s. It held for a while but by 2014 Baupost had sold out (likely around $40s). We don't have public confirmation of exact prices, but Klarman generally made a moderate gain. Mason Hawkins' Southeastern Asset Management (Longleaf Partners) was also an Oracle shareholder in the 2000s/early 2010s, attracted by Oracle's high free cash flow and moat. Southeastern pushed Oracle to do more buybacks when the stock was low. Longleaf's average buy might have been ~$30 and it trimmed as the stock rose to high-$30s by 2014. Southeastern no longer lists Oracle among top holdings, indicating they exited as the price approached their appraisal of fair value back then (perhaps in the $40s).

Other investors: David Tepper's Appaloosa at one point held Oracle around 2019, but not a major position. Yacktman Asset Management, known for focusing on cash-rich businesses, held Oracle in the mid-2010s as well. Yacktman likely bought in low-$30s and sold in $40-$50 range as the stock appreciated. Many value managers saw Oracle as an undervalued cash cow when it traded at ~10x earnings with lots of FCF in the mid-2010s. As the stock re-rated to higher multiples in recent years (now ~20x earnings), some of those traditional value funds rotated out, locking in gains.

Current Value Investor Holdings: There aren't many high-profile value investors still holding Oracle in 2025, largely because the stock's valuation is higher and it's more of a growth story now. One exception: Investco Ltd. (formerly OppenheimerFunds) in some of their value funds still hold Oracle as a core large-cap value position due to its stable cash flows and dividend. But activist or deep value involvement is absent - Oracle's transformation and share price increase removed the "deep value" discount.

Average Buy/Sell Prices & Holding Periods: To summarize a few known cases:

• Buffett's Berkshire: Buy ~$50, Sell ~$50 (held ~1 quarter, 2018). Exited completely.

• Mason Hawkins/Longleaf: Buys in $30s (early 2010s), Sold in $40s (by mid-2010s). Likely earned ~30-50% over several years. No current holding.

• Seth Klarman/Baupost: Buys ~$25-30 (c.2010), Sold ~$40 (by 2014). Gain ~50%+ over ~4 years.

• Donald Yacktman: Buys ~$30 (2012-ish), Sells ~$45-50 (2016-ish). Good gain ~50-60%.

• ValueAct (activist fund) - interestingly, never took a big stake in Oracle (they did in Microsoft, Adobe, etc., but Oracle already had Ellison control).

• Current holders among long-term value-leaning institutions include some insurance companies and pension funds which likely have an average cost basis much lower (some have held Oracle since the '90s).

The absence of activists or large value funds currently suggests they consider Oracle fairly valued or even somewhat expensive now (at ~25x trailing EPS). However, one might argue Oracle's cloud growth could justify it as more of a growth stock.

Are They Still Holding & at What %: As noted, most classic value investors who bought Oracle at lows have taken profits. Those that remain tend to be broad index or growth investors. For instance, PRIMECAP Management (a long-term oriented manager, not strictly value) holds about 1.5% of Oracle's shares; they've held Oracle for decades. Primecap's cost basis could be very low (they likely accumulated in early 2000s at splits-adjusted single digits), and they still hold because they believe in Oracle's long-term innovation.

In terms of concentration: Larry Ellison himself is arguably the ultimate "value investor" in Oracle - he's held his stake since founding, never diversifying much. His cost basis is essentially near zero (initial founder shares), and he now owns ~40%. That's an extreme case of conviction and alignment (though as founder, it's expected).

One specific "value investor" often tracked is Joel Greenblatt (through Gotham funds) - he had Oracle at times as a magic formula pick (high ROC, earnings yield). It appears in some of his periodic holdings, but likely as part of a quantitative strategy, not a concentrated bet.

In conclusion, value investors who got in earlier have largely realized substantial returns as Oracle's P/E expanded and the business proved resilient. Their average buy prices were mostly in the $20s-$30s, sells in $40s-$50s (some a bit early in retrospect). Oracle's shareholder base now is more dominated by generalist institutional investors and index funds rather than concentrated value funds. That said, if Oracle's stock were to pull back significantly, it wouldn't be surprising to see value-oriented funds step in again given Oracle's strong free cash flow and entrenched competitive position.

Intrinsic Value Analysis (Warren Buffett's Method)#

To estimate Oracle's intrinsic value in a Warren Buffett-style framework, we perform a Discounted Cash Flow (DCF) focusing on Owner Earnings (free cash flow) projections. Buffett's approach emphasizes using conservative assumptions: a discount rate of 10-15%, a margin of safety of 30-50%, and a terminal growth rate below 3% (below long-term GDP). We'll derive an intrinsic value per share and compare it to the market price, then estimate the implied expected return at the current price.

Inputs for DCF: We use Oracle's current financials as a base. In FY2024, Oracle's free cash flow (FCF) was about $11.8 billion. (Owner earnings would be similar to FCF since Oracle's maintenance capex is roughly equal to depreciation over time; Oracle's FY2024 operating cash flow was $18.7B and capex ~$6.9B, yielding FCF ~$11.8B.) Shares outstanding are ~2.82 billion, so FCF per share is about $4.18. Oracle also paid out $1.60 in dividends, leaving ~$2.58 per share in retained cash flow.

Scenario 1: Conservative (Lowest growth in last 10 years) Oracle's lowest annual revenue growth in the past decade was around -3% (FY2016), but that was an anomalous decline. Excluding negative outliers, the lowest positive growth was ~2-3%. To be conservative, we can assume 0% revenue growth for a few years (flat revenue) and only nominal growth thereafter. However, Oracle's margins have been rising with cloud mix, so even flat revenue could yield some FCF growth. But let's be very cautious: assume FCF grows just 2% annually for the next 5 years (below inflation), then 1.5% terminal growth (below GDP). This essentially models a stagnation scenario.

• Starting FCF = $11.8B (Year 0).

• Years 1-5: grow at 2% (so Year 5 FCF ~ $13.0B).

• Terminal growth = 1.5%.

• Discount rate = 10% (Buffett's minimum hurdle for stable large companies).

Calculating DCF: Present Value of 5-year cash flows ≈ $11.8B * [1 - (1.02)^5 / (1.10)^5] / (10% - 2%) (this formula is approximate for growing annuity). Let's do it stepwise: Year 1 FCF $12.0B, PV at 10% = $10.9B; Year 2 FCF $12.3B, PV^2 = $10.2B; Year 3 $12.5B PV = $9.5B; Year 4 $12.8B PV = $8.9B; Year 5 $13.0B PV = $8.3B. Sum of PV 5-year FCF ≈ $47.8B.

Terminal value in Year 5 = Year6 FCF ($13.2B) / (Discount 10% - Terminal 1.5%) = $13.2B / 8.5% ≈ $155.3B. PV of terminal = $155.3B / (1.10)^5 ≈ $96.5B.

Total intrinsic enterprise value ≈ $47.8B + $96.5B = $144.3B. Adjust for Oracle's net debt (~$53B debt - $10B cash = $43B net debt as of 2024) gives equity value $101.3B. Divide by 2.82B shares = $35.90 per share. This would be an extremely pessimistic valuation. It's well below the current market price ($105), implying the market is not pricing such stagnation.

However, $35.9 is likely too low because Oracle's actual growth prospects are better than zero. Note this scenario essentially values Oracle as if it never really grows and barely keeps pace with inflation. Buffett's margin of safety is often applied to such a conservative scenario; here the current stock price (~$105) is almost 3x this, indicating no margin of safety if one believed this stagnation scenario. But Oracle is actually growing faster, so we need a more reasonable scenario.

Scenario 2: Average Growth (Past 10-year average) Over the last decade, Oracle's revenue CAGR was ~3-4%, but earnings and FCF grew a bit faster (due to buybacks and margin expansion). Let's assume Oracle can grow FCF at, say, 6% annually for next 5 years, then taper to 2% terminal growth. 6% is closer to Oracle's recent organic growth (FY2023 was 17% due to Cerner, FY2024 6%; management expects double-digit in FY2025 with AI/cloud boost, but we'll moderate to 6% average).

• Year 1 FCF ~ $12.5B, Year 5 FCF ~ $15.8B (growing 6% compound).

• Terminal from Year6 (grow at 2%): Terminal value in Year5 = $15.8B * (1.02) / (10% - 2%) = $16.1B / 8% = $201.25B, PV back 5 years = $201.25 / (1.10)^5 ≈ $125B.

• PV of first 5-year FCF: Year1 $12.5B (PV $11.4B), Year2 $13.3B ($11.0B), Year3 $14.1B ($10.6B), Year4 $14.9B ($10.2B), Year5 $15.8B ($9.8B). Sum ≈ $53.0B.

Enterprise value ≈ $53B + $125B = $178B. Minus net debt $43B gives equity ~$135B. Per share = $47.9. That's still under half of the current price. The conservative 10% discount rate is weighing heavily. If Oracle truly can grow 6% for many years, one might argue a 10% required return is a bit high for such a stable, cash-rich business (some might use 8% for the discount, given low interest rates recently - but Buffett tends to stick to ~10% as a hurdle).

Even this scenario shows intrinsic value (~$48) well below market ~$105. Does that mean Oracle is overvalued? Not necessarily - it may mean the market is pricing in higher growth or using a lower discount rate. Let's analyze expected return implied by current price:

Current Market-Implied Expectations: With the stock ~$105, let's see what discount rate would equate DCF to ~$105 using Scenario 2 growth. If we set margin of safety to 0% (i.e. accept current price as "fair"), what discount rate yields $105? We adjust the discount rate downward until the DCF equals ~$105.

At 8% discount rate, for example:

• Terminal (in Year5) with 2% growth would be $15.8B *1.02 / (0.08-0.02) = $16.1 / 6% = $268B, PV back5 at 8%: $182B.

• PV of years1-5 at 8%: Year1 $12.5B/1.08 = $11.6B, Y2 $13.3/1.08^2=$11.4B, Y3 $14.1/1.08^3=$11.1B, Y4 $14.9/1.08^4=$10.9B, Y5 $15.8/1.08^5=$10.7B, sum $55.7B.

• EV ≈ $55.7 + $182 = $237.7B, equity minus debt $237.7-43 = $194.7B, per share ~$69.

At 6% discount (which is probably too low to consider as a required return), EV becomes enormous:

• Terminal at 6%: $16.1B/(0.06-0.02)= $16.1B/4%=$402.5B; PV back5 at 6% = $300B.

• PV of 5yr flows at 6% ≈ $60B.

• EV ≈ $360B, equity ~$317B, per share ~$112.

So at ~6% required return, the stock looks slightly undervalued (intrinsic ~$112 vs $105 price). At ~7% discount, we'd get intrinsic near current price.

Thus, the implied expected return for an investor buying at $105 assuming the scenario (6% growth, 2% terminal) is roughly in the 6.5-7.5% range. Indeed, solving for discount rate that gives ~$105 value yields ~7% expected return. This suggests the market is pricing Oracle like a quasi-bond with growth - investors may be willing to accept ~7% annual returns given Oracle's cash generation and current low interest rate environment.

Buffett's method, however, would demand at least 10% return plus a margin of safety (say valuing at 15% discount rate and then buying at 30% below that intrinsic value). Under those stringent criteria, Oracle would not qualify as a "buy" today - it's too popular and richly priced now. Back when Oracle was $45 and largely unloved (~2017), it likely met those thresholds (which is why Berkshire bought then). But after doubling, the margin of safety is gone.

To further illustrate, Margin of Safety analysis: If our intrinsic value at 10% discount with 0% growth scenario was $36 and with moderate growth $48, even the optimistic scenario gave ~$70 at an 8% discount. Buffett often wants a 30-50% margin of safety - current price is way above those conservative values, meaning no margin of safety exists at current price under typical Buffett yardsticks.

However, one might argue we were too conservative in assumptions. Oracle's own guidance implies potentially higher growth (they forecast FY2026 revenue to be 16%+ cc growth, with cloud growth 40%+). If Oracle manages say 10% FCF growth for 5 years then 3% terminal, at 10% discount the intrinsic might rise significantly (quick calc: Year5 FCF ~$19B, terminal ~$272B PV ~$169B, plus PV of flows ~$57B, EV ~$226B, equity ~$183B, per share ~$65). Still below $105. Essentially, to justify $105 using a 10% discount, Oracle would need something closer to 15% annual FCF growth for a decade - a very tall order for a company of its size. The fact that the stock trades at $105 indicates investors are likely using a lower required return (7-8%) due to Oracle's stability or expecting sustained double-digit growth which they believe can last a long time (given the AI/cloud tailwinds Ellison touts).

Conclusion on Intrinsic Value: Using Buffett's traditional 10% discount rate and adding a margin of safety (30%), Oracle's intrinsic value would come out far below the current market price. For instance, even a somewhat optimistic DCF might yield ~$60 intrinsic, and a 30% margin of safety target buy price would be ~$42 - which is about where Oracle traded in 2016. In other words, from a pure value perspective, Oracle was a bargain back then, but not now after its rally.

Buffett often emphasizes quality of the business and growth prospects, so he might accept a lower yield for a stronger franchise. Oracle is a strong franchise, but perhaps he felt he didn't fully understand the cloud competitive dynamics, hence he sold. If one were to apply a slightly lower discount (reflecting lower interest rates and Oracle's strong moat), say 8%, intrinsic might be in the $70 range - still below market price (no margin of safety).

Thus, by Buffett's method, Oracle's stock at ~$105 appears above the range a strict value investor would pay. The expected return at $105 (with moderate assumptions) is around 7% annually, which may not meet Buffett's 10% hurdle.

For current Oracle shareholders, the expected return can be derived by finding the discount rate that sets DCF = $105. This appears to be around 7% as mentioned. That 7% would be the approximate equity IRR from owning at this price, given moderate growth assumptions. If one required 10%, one would want to pay much less for the same cash flows.

It's important to note, however, that Oracle's future could surprise on the upside (e.g. if AI workloads drive much faster growth, or if margins expand more than assumed). If Oracle can grow FCF 10%+ for a decade (entering a new renaissance with cloud/AI), the intrinsic value under Buffett's method would be much higher - potentially justifying the current price or more. For instance, plug 10% growth for 10 yrs, 3% term, 10% discount: intrinsic per share might approach $100 (just roughly). So the market might be betting Oracle is at an inflection point where growth accelerates (thus compressing the payback period).

Buffett's likely view: Buffett prefers simple, predictable businesses. Oracle has some predictability (huge recurring support revenue), but also tech risk. Buffett did not hold on, implying he didn't see a wide margin of safety. Using his margin of safety principle, one could say if one demanded a 50% margin, they'd want to buy Oracle at ~$30 (which was feasible a decade ago but not now). Those who did are sitting on large gains.

In summary, intrinsic value (DCF) estimates for Oracle vary widely with assumptions. Under conservative Buffett-like assumptions (10%+ discount, low growth), intrinsic value is far below market price. The current price seems to be baking in either a lower required return or higher growth. If one strictly follows Buffett's method, Oracle would be considered overvalued at $105 and not offering a margin of safety. Conversely, the implied expected return at the current price is around 7% per year (in line with a bond-like equity). Investors may accept that given Oracle's competitive strengths and the lower yields available elsewhere, but it is lower than Buffett's typical 10% hurdle.

Latest Quarter (FY2025 Q4) Earnings Highlights#

Oracle's most recent earnings report was for Fiscal 2025 Q4 (quarter ended May 31, 2025), and it was very strong, capping a solid year:

• Revenue: Q4 2025 revenue was $15.92 billion, up 11% year-over-year. This growth was driven by Oracle's cloud businesses. For the full FY2025, total revenue was $57.4B, up 8% (or +9% in constant currency) - an acceleration from 6% the prior year. Importantly, Oracle's Cloud revenue (IaaS + SaaS) in Q4 was $6.7B, up 27%, showing the momentum in Oracle's cloud offerings.

• Cloud Segments Detail: In Q4, Cloud Infrastructure (OCI) revenue jumped 52% to $2.0B, and Cloud Applications (SaaS) revenue rose 12% to $3.7B. Specific SaaS products were highlighted: Fusion Cloud ERP revenue up 22% to $0.8B, NetSuite ERP up 18% to $0.8B. These indicate Oracle's flagship cloud ERPs are growing double-digits, capturing market share. For full-year FY25, Cloud Services & License Support revenue was $44.0B, up 12% - now 77% of total revenue. Cloud License & On-Prem License was $5.2B, up 2% (stabilizing after prior declines). The Cerner acquisition falls mostly under Cloud Services now (Oracle is converting Cerner customers to Oracle Cloud Infrastructure, which bolstered IaaS growth).

• Profitability: Q4 GAAP operating income was $5.14B; GAAP operating margin 32%. Non-GAAP op margin was higher at 44%. GAAP net income was $3.4B for Q4, up ~16% (from $3.1B a year ago). GAAP EPS was $1.19, up from $1.11. On a non-GAAP basis, EPS was $1.70 (+4%). For full year FY25, GAAP net income was $12.4B, up 18% (FY24 was $10.5B). GAAP EPS FY25 = $4.34, up ~17%. This improved profitability partly reflects Cerner synergies and strong cloud revenue scaling.

• Cash Flow and Financials: FY2025 operating cash flow was $20.8B, up 12%. Free cash flow was ~$15B (after $5.0B capex). Oracle is using cash to pay down debt (they repaid ~$6B of debt in FY25) and fund dividends. Oracle ended FY25 with $9.4B in short-term deferred revenue (indicative of advance payments). Net debt remains around $40B, but Oracle's leverage ratio is declining with EBITDA growth.

• Forward-Looking Commentary: CEO Safra Catz said FY25 was strong but expects FY26 to be even better, projecting "double-digit revenue growth" with each quarter accelerating. She specifically guided that total cloud (IaaS+SaaS) growth would increase from 24% in FY25 to over 40% in FY26 - a very bullish outlook. Q1 FY26 revenue was guided up 8-10%. Chairman Larry Ellison highlighted big AI cloud wins: Q4 included over $2B in AI cloud contracts (notably a huge partnership with OpenAI to train ChatGPT on Oracle Cloud). Ellison said "record" demand for Oracle Cloud is driven by AI workload training, and that OCI's unique architecture is attracting customers (e.g. 30 new AI contracts in Q4 worth $12.5B). Oracle also announced multicloud partnerships (with Microsoft Azure and now Google Cloud) where Oracle will operate cloud regions inside those platforms, making Oracle's database available seamlessly in other clouds - expected to "turbocharge" Oracle's cloud growth per Ellison. These statements indicate Oracle is positioning for perhaps its fastest growth in decades, if AI-related workloads ramp as anticipated.

• Dividend and Shareholder Returns: Oracle's Board declared a $0.50 quarterly dividend for July 2025, up 25% from the prior $0.40. This marks Oracle's second dividend hike in less than 2 years (it was $0.32 in 2022). The willingness to raise the dividend aggressively signals confidence in cash flows. No mention of specific buyback spending was in the press release, but the authorization stands as previously discussed.

• Business Segments Performance: Cloud services strength overshadowed the older segments. Oracle's services consulting segment (the low-margin business) was relatively flat or slightly down (no detailed mention, likely still ~$5B/year at low single-digit decline). Hardware was not specifically mentioned in the top highlights - implying it's no longer material to growth (likely continued modest decline, but any negative impact is small given hardware is <6% of rev).

Overall, the latest quarter showed Oracle exceeding expectations on cloud growth and issuing very upbeat guidance for the coming year. The market reacted positively - Oracle's stock hit a 52-week high on these results. Analysts noted that Oracle's cloud bookings (RPO up 41% to $138B) indicate future revenue is locked in at a high growth trajectory.

To summarize in bullet form, Q4/FY25 results highlight:

• Strong Growth: Total rev +11%, Cloud rev +27% in Q4; FY25 rev +8%.

• Cloud Infrastructure boom: OCI +52% in Q4, fueled by demand for Oracle's GPU cloud for AI.

• Healthy Profit: FY25 GAAP EPS $4.34, +17% YoY; operating margins ~29% GAAP (44% non-GAAP) stable.

• Cash Flow & Dividend: $20.8B OCF in FY25; dividend hiked 25% to $0.50/qtr.

• Backlog & Outlook: RPO (contracted backlog) $138B (+41%); FY26 guided for accelerating cloud growth >40%. AI and multicloud partnerships expected to drive unprecedented cloud uptake.

In essence, Oracle's most recent earnings underscore that the company's cloud transformation is gaining significant traction. This successful quarter and optimistic forward guidance help explain the stock's strong performance and valuation - investors are factoring in a new phase of robust growth for Oracle that could persist for several years. As long as Oracle executes on fulfilling its massive cloud backlog (converting RPO to revenue) and manages the associated capital investments, the near-term outlook is quite positive.

Financial Research#

We now turn to Oracle's key financial metrics, evaluating its valuation ratios, cash flow and profitability trends, and balance sheet health over the past 10 years. All figures are in USD. Historical data are gathered from Oracle's annual reports and financial databases, cross-validated for consistency. Below, we present tables of metrics for FY2015 through FY2024 (Oracle's fiscal year ends May 31).

Valuation Metrics (FY2015 - FY2024)#

The table below shows Oracle's stock price, market capitalization, book value, and common valuation ratios over the last decade, along with return on equity and return on invested capital:

Sources: Year-end prices from market data; shares outstanding from annual reports to compute market cap. Book value (shareholder's equity) from balance sheets. P/E = price / diluted EPS; P/B = price / (book value per share) - note P/B not meaningful in years equity was negative (2022-23). ROE and ROIC from Oracle's filings & Macrotrends.

Notes: Oracle's book value plunged in 2019-2022 due to massive stock buybacks (retained earnings were used to repurchase shares) and the Cerner acquisition goodwill write-up which, combined with buybacks, resulted in negative equity in 2022-2023. Thus P/B and ROE are not meaningful for those years (ROE hitting extremely high or negative values when equity was near zero or negative) - the ROE figures for 2019 onward are distorted and not reflective of operational performance (in 2024 equity turned positive $9.24B, making ROE calcuable again at ~114%, but this is also not typical in steady state). It's more sensible to look at Return on Invested Capital (ROIC) as a cleaner measure (which adjusts for debt and excludes buyback effects). Oracle's ROIC hovered in the mid-teens consistently - e.g. ~16-19% most years, dipping when earnings fell in 2018 and 2022, but recovering to ~17.6% in 2024. This solid ROIC indicates Oracle continues to generate good returns on capital employed, reflecting its durable competitive advantages.

From the valuation metrics, we observe:

• Market Cap more than tripled from ~$142B in 2015 to ~$467B in 2024, driven by stock price appreciation and a bit by reduced share count. Notably, share count fell ~40% over the decade (boosting per-share metrics).

• P/E Ratio: Oracle's P/E expanded from ~14x in 2015 to over 40x by 2024. Part of the high FY2024 P/E (~44.6x) is because FY2024 GAAP EPS ($3.71) includes a large one-time tax expense; using non-GAAP EPS $5.56, the P/E was ~29.8x - still much higher than historical averages ~15x. The market rerated Oracle as a cloud growth stock in recent years (plus low interest rates justified higher multiples).

• P/B Ratio became not meaningful when equity was negative. Even now at $9.24B equity in 2024, P/B ~50x, which is not a useful metric given Oracle's capital-light model and negative equity history from buybacks. Essentially, Oracle's market cap is based on intangible asset values (brand, customer relationships, IP) not captured on balance sheet. So P/B is not a relevant valuation tool for Oracle currently.

• ROE was healthy ~19-25% up to 2017, collapsed in 2018 due to the $9.5B one-time tax charge (net income plunged, equity still positive, ROE ~7%), then ROE became sky-high once equity shrank (2019 onward). The extreme ROE in 2021 (160%) and 2024 (114%) is a byproduct of tiny equity base rather than an actual jump in performance. Investors focus on ROIC or profit margins instead.

• ROIC is stable mid-teens, indicating Oracle continues to allocate capital effectively. Even after adding substantial debt for acquisitions, Oracle's ROIC remained ~16-17% in recent years, above its weighted cost of capital (~8%), thus creating value.

Cash Flow Metrics (FY2015 - FY2024)#

Below is Oracle's income and cash flow performance over the last 10 years, including revenue, various profit figures, margins, and free cash flow:

Sources: Revenue from Oracle annual results. Gross profit from Macrotrends (annual). Operating income from financial statements. Net income from statements. Margins computed (net margin = net income/revenue). Net margin gain = change in net margin vs prior year (in basis points). Free Cash Flow = Operating Cash Flow - Capital Expenditures (from Oracle cash flow statements). FY2024 figures from latest 10-K and press release.

Key observations from cash flow metrics:

• Revenue Growth: Over FY2015-2021, Oracle's revenue was relatively flat (~$38-40B), reflecting legacy business stagnation and cloud not yet offsetting declines. A real jump occurred in FY2022-2023 (to $49.95B in FY23) thanks to Cerner acquisition (+$5B) and organic cloud growth. FY2024 revenue grew 6% to $52.96B, highest ever. So revenue CAGR for decade ~3.5%. The acceleration in last two years is noteworthy.

• Gross Profit & Margin: Gross profit steadily rose from ~$30B mid-decade to $37.8B in FY2024. Gross margin dipped slightly around FY2018-2019 as cloud SaaS margins were initially lower, then rebounded to ~71% in FY2024 (GP $37.82B on $52.96B = 71.4%) vs ~80% in mid-2010s. The decline in gross margin is due to a higher mix of cloud infrastructure (which has significant cost of delivery). However, Oracle's cloud gross margin has been improving as it scales. Gross margin in FY2022 dropped to ~79%->79.0% (from ~80% prior) with Cerner (healthcare business has lower margins), then down to 72.8% in FY2023 due to heavy cloud infra costs, slightly up to ~71.4% in FY2024 as cloud scale improved.

• Operating Income & Margin: Operating income was ~$13-15B through 2015-2017 (op margin ~34-36%). In FY2018, op income held $13.3B (margin 33.7%) despite lower tax-adjusted net. In FY2019, operating income still ~$13.5B (34.3% margin). It peaked at $15.21B in FY2021 (37.6% margin) as Oracle cut costs during pandemic and had high-margin support rev. But FY2022 saw op income plunge to $10.93B (margin 25.7%) due to Cerner integration costs (Oracle incurred ~$4.7B acquisition-related and $3.0B amortization in FY22). In FY2023, op income rebounded to $13.09B (26.2% margin) as some one-time costs subsided. FY2024 op income $15.35B, margin ~29.0% - moving closer to historical 30%+ range. We see Oracle's operating margin dipped significantly in 2022 due to investments and amortization (also cloud's lower margin) but is now recovering as cloud scale improves and Cerner costs normalize.

• Net Income & Net Margin: Net income followed a bumpy path largely due to tax law changes and acquisitions. It was ~$9-11B in mid-2010s (net margin ~24-26%). FY2018 net was only $3.59B (margin 9.1%) because of a one-time $6.9B tax charge from the 2017 U.S. Tax Cuts and Jobs Act (repatriation tax). Excluding that, normalized FY2018 net would have been ~$10.5B (25% margin). FY2019 jumped to $11.08B (28.1%) as that charge didn't repeat. FY2020 $10.14B (26.0%), FY2021 $13.75B (34.0%) - the highest ever, boosted by a one-time investment gain (Oracle sold some shares of an investment for ~$2.3B profit in 2021, and had lower tax that year). Then FY2022 net dropped to $6.72B (15.8%) due to Cerner-related expenses, interest on new debt, etc. FY2023 recovered to $8.50B (17.0%). FY2024 net was $10.47B (19.8% margin). So aside from anomalies, Oracle's normalized net margin has been ~24-28% historically, dipping to ~17-20% now as cloud infra costs and amortization weigh. The general trend: net margin was very high in legacy software days (~25%), shrank temporarily with big charges (FY18, FY22), and is now around 20% moving upward as cloud becomes profitable at scale. The net margin gain row shows the big swings: -1590 bps in 2018 (tax), +1900 bps in 2019 (tax normalizing), -1820 bps in 2022 (acquisition), then +280 bps in 2024 as integration progresses. Excluding those one-offs, underlying margin improvement came from cost control and share buybacks (which reduce share count, not net margin but boost EPS).

• Free Cash Flow (FCF): Oracle has been a cash machine. FCF ranged $11-13B through 2015-2017. FY2018 FCF was $13.65B, an all-time high at that point. It dipped slightly to ~$11.6B in 2020 due to lower cash earnings and some working capital. FY2021 FCF surged to $13.75B (roughly matching net income due to strong collections and low capex). However, FY2022 FCF fell sharply to $5.03B - this is notable. The decline stemmed from Cerner acquisition effects: Oracle's operating cash flow was hit by one-time costs and deferred revenue adjustments, plus capex jumped as Oracle invested in cloud data centers and Cerner data centers. Indeed, CapEx in FY2022 was ~$6.7B (versus $1.0-1.5B historically), mostly for cloud expansion. That huge capex caused FCF to drop. By FY2023, FCF recovered to $8.47B (capex still elevated around $7B, but operating cash flow improved). FY2024 FCF was $11.81B, nearly back to peak levels, as capex moderated slightly ($5.9B) and operating cash flows grew with cloud bookings. We can see Oracle's FCF margin historically ~30-35% (e.g. 2015 FCF $13.19B on $38.23B = 34.5%) gradually came down to ~22% in 2024 ($11.81B on $52.96B) as the business mix changed. Still, a 22% FCF margin is very strong for a company investing heavily in cloud.

The cash flow history highlights Oracle's enormous cash generation and the temporary impact of large strategic investments. The drop in FCF in 2022 was concerning at the time, but the rebound in 2023-2024 shows those were transitory factors. With Oracle now emphasizing cloud, we expect capex will remain higher than in the 2010s (to keep adding capacity), but operating cash flow also rising strongly, so FCF should trend upward. Indeed, FY2025 operating cash flow was $20.8B; after capex $5B, FCF$15B - significantly above FY2024's $11.8B, indicating Oracle is already exceeding its past FCF highs.

Balance Sheet Metrics (FY2015 - FY2024)#

Now we examine Oracle's assets, debt, and capital structure ratios over the past decade:

Sources: Balance sheet data from Oracle's 10-K for FY2024 (which provides comparative figures) and earlier 10-Ks. Equity values from prior table.

Key points on balance sheet:

• Assets: Oracle's total assets hovered around $110-130B through 2015-2018. In 2019, assets dropped to $108B (Oracle spent cash on buybacks). By 2021, assets grew to $131B (cash buildup from debt issuance). In 2022, assets fell to $109B after paying $28B for Cerner (cash went down, goodwill up but also share buybacks reduced assets). Then 2023-2024 assets rose again to $130B+ and $142.8B, mainly due to Cerner goodwill and intangible assets plus organic growth. A large portion of assets is goodwill/intangibles: after Cerner, goodwill alone was ~$60B in 2024 (the buy of Sun, PeopleSoft, Siebel, etc., plus Cerner, accumulate).

• Debt: Oracle's total debt (long + short-term) was about $38B in 2015. It ticked up to $61B by 2018 due to debt-funded buybacks. Oracle then added more debt in 2020-2021 (taking advantage of low interest rates) - debt peaked at $90.9B in 2022 after Oracle borrowed ~$15B to fund Cerner and had earlier $14B debt raise in 2020 for buybacks. In 2023, debt $93.3B (including Cerner's assumed debt). In 2024, debt hit $100.1B - Oracle issued some new bonds in late 2022/early 2023 to refinance and also had lease liabilities accounted. However, importantly Oracle has been paying down this debt in FY2025 (now ~$91B as of Q4 FY25). But at FY24, $100B debt is high - though Oracle also has about $8.4B cash. Net debt ~ $91.7B at FY24.

• Cash: Oracle's cash & equivalents were ~$22B mid-2010s, surged to $46.6B by 2021 as Oracle borrowed money (they raised $20B in bonds in 2020 while pausing buybacks, accumulating cash). Then Oracle spent ~$28B on Cerner (cash down to $8.8B in 2023). FY2024 cash $8.44B. This is low relative to debt, but Oracle generates $15-20B cash per year, so it doesn't need a huge cash buffer. They're using cash flow to service and reduce debt (and to pay dividends).

• Equity: Shareholders' equity was $49B in 2015, steadily fell to $22.4B by 2019 due to share repurchases (Oracle spent far more on buybacks than it earned in profit, thus reducing retained earnings). In 2021 equity was just $5.95B, and in 2022 it turned negative $5.77B (first time in Oracle's history) because Oracle took on goodwill from Cerner (~$23B intangible) and financed it with debt, plus continued buybacks - liabilities exceeded assets slightly. A negative equity for a company like Oracle is not alarming per se (it's an outcome of capital allocation). By 2024, with retained earnings from profits, equity is positive $9.24B. This is still small, reflecting that Oracle has effectively returned most of its accumulated earnings to shareholders already. The low equity magnifies metrics like ROE (as discussed) but doesn't impact operations (Oracle can easily service debt with cash flows).

• Leverage Ratios: Debt/Equity skyrocketed as equity shrank. It was ~0.8x in 2015, then >1.3x by 2018. By 2019, D/E 2.56x (still manageable). But once equity got very low, D/E became meaningless. 2020 shows 5.68x (equity $12.7B vs debt $72B), 2021 14x (equity $5.95B, debt $84B). In 2022-2023, equity was negative or tiny, so D/E not meaningful. 2024's D/E 10.83x (equity $9.24B vs debt $100B). These ratios look extreme, but one must recall Oracle's stable cash flows make debt less risky than equity suggests. Better to look at Debt/EBITDA or similar: At end FY24, net debt ~$92B, FY24 EBITDA ~$20B, so net debt/EBITDA ~4.6x. That's high for a tech firm, but Oracle plans to deleverage quickly (by FY2025 Q4, net debt/EBITDA is down to ~3.2x, heading to <3x by FY2026).

• Debt/Assets: This shows the portion of assets funded by debt. It rose from ~34.5% in 2015 to 83% in 2022. It's about 70% in 2024. Oracle's capital structure is thus quite leveraged at face value: 70% debt-financed assets. But note, assets include a lot of goodwill which doesn't require funding maintenance. Oracle's interest coverage remains healthy (5x in FY2024) because its operating profits cover interest expense ($3.5B) multiple times. The trending down of debt/assets in 2024 vs 2022 suggests equity is rebuilding from profits.

• Current Ratio: Though not tabulated above, Oracle historically had a current ratio ~2.5x in mid-2010s (lots of cash vs short-term liabilities). By 2023 it was near 0.8x (because Oracle used cash and had high short-term debt). At FY2024 it improved somewhat with strong cash gen - current assets $26.9B vs current liabilities $35.1B, ratio ~0.77. This is below 1, but Oracle can handle it due to continuous cash inflow and ability to refinance. They also have significant long-term debt ($95B of the $100B is long-term).

• Credit Ratings & Risk: Oracle is rated investment grade (Moody's Baa2, S&P BBB+) with stable outlook, reflecting the expectation it will reduce debt gradually. The high absolute debt is balanced by Oracle's robust cash flow. Indeed, Oracle's interest coverage in FY2024: Op income $15.35B vs interest $3.51B is ~4.4x, which is moderate. With interest rates on recent debt fixed in 3-4% range, and with paydown ongoing, coverage will improve.

Overall, the balance sheet shows Oracle intentionally leveraged up to fund shareholder returns and acquisitions, running with negative or minimal book equity for the benefit of optimizing capital structure. This is a conscious choice by management, reflecting confidence in stable cash flows. While leverage is higher than many peers, Oracle is now prioritizing debt reduction (e.g., they indicated reducing debt by ~$7-8B per year post-Cerner using free cash after dividends). By mid-2025, net debt is already down to ~$80B. This will bring metrics like Debt/EBITDA back to ~3x, a comfortable range.

In summary:

• Liquidity: Oracle has lower cash now but enormous internal cash generation. Short-term ratio <1 is not concerning given predictable cash inflows.

• Solvency: High debt load, but manageable relative to cash flows. The negative equity in recent years was a byproduct of policy (not due to losses).

• Capital Structure: Oracle shifted to a more debt-heavy structure to minimize WACC and return money to owners. This boosted ROE (as seen) and EPS growth via buybacks. There is risk if interest rates spike or cash flows falter, but currently interest obligations are well-covered.

Growth Metrics#

We examine Oracle's growth rates for revenue, net income, and owner (free) cash flow over the past decade:

Sources: Growth rates computed from tables above. Owner FCF = free cash flow as calculated; growth sometimes not meaningful if prior year aberrant.

This shows:

• Oracle's revenue growth was mostly low single-digits or negative for much of the decade, reflecting a mature business transitioning to cloud. It only broke out with double-digit growth in FY2023 (+17.7%, largely due to Cerner). FY2024's 6% is the highest organic growth in many years. So revenue CAGR 2015-2024 is ~3.5%. But trailing 2-year CAGR (2022-2024) is ~11.5%, indicating acceleration in the recent period thanks to cloud momentum and acquisition.

• Net income growth was volatile. Excluding one-offs: typical net income growth (adj for buybacks) was mid-single digits in stable years. The wild swings in 2018 (-62%) and 2019 (+209%) distort averages; those were due to tax changes. Similarly 2022 big drop (-51%) with Cerner costs, then 2023 big bounce (+27%) as those costs eased. If we average through the bumps, net income is roughly flat to slight growth over the decade (FY2015 $9.94B to FY2024 $10.47B, that's only +5% total). However, EPS grew much more (~+80% over decade) because share count shrank ~45%. Thus, EPS CAGR was about 7-8% from 2015 to 2024 (non-GAAP EPS $2.38 in FY2014 to $3.71 GAAP / $5.56 non-GAAP in FY2024).

• Owner's Earnings (FCF) Growth: Also uneven. Over 2015-2021, FCF rose modestly (2015 $13.19B to 2021 $13.75B, just +4% total). Then huge drop in 2022, then huge rise by 2024 beyond old highs. The +68.5% in 2023 and +39.4% in 2024 emphasize recovery from the low 2022 base. If we normalize, say average FCF 2015-2017 vs 2022-2024, it's gone from ~$12B to ~$11B - essentially flat. But looking forward, FY2025 is on track for ~$15B (as noted). So future owners' earnings growth might be re-initiating after a lull.

In summary, Oracle's past decade growth was lackluster overall (stalled in mid-2010s, picking up in early 2020s). The numbers reflect a business that underwent a transition period where new cloud revenue replaced declining legacy streams, with a big acquisition thrown in. Only recently have we seen meaningful top-line and cash flow growth, implying Oracle may now be at the start of a new growth cycle (cloud & AI). Investors are betting the trend from FY2023-2024 (double-digit FCF growth) continues into coming years.

Company Assessment Based on Metrics#

Based on the comprehensive metrics above, here's what they suggest about Oracle's financial condition and performance:

• Profitability & Efficiency: Oracle remains a very profitable enterprise. Gross margins ~70% and operating margins ~30% show strong pricing power and operational discipline. While margins dipped during transitional years (cloud investments, Cerner integration), Oracle's ability to rebound to ~29% op margin in 2024 speaks to effective cost management. Return on invested capital ~17% is robust, indicating Oracle generates healthy returns on its acquisitions and capital expenditures - an important sign that investments in cloud and R&D are yielding value. The spikey ROE is less informative due to capital structure changes, but excluding those anomalies, Oracle's core business throws off lots of profit relative to its tangible capital employed, a hallmark of a high-quality business (wide moat in databases and enterprise apps).

• Growth Profile: Historically low growth metrics reflect Oracle's late transition to cloud and saturation of traditional markets. This was a key bear point for Oracle in the 2010s. However, the recent acceleration in revenue (+17% in FY23, +11% in latest quarter) combined with management's guided 40% cloud growth next year suggests Oracle's growth profile is markedly improving. If achieved, Oracle would transform from a slow-growth to a moderate/high-growth company, warranting a higher valuation multiple (which we've seen the market assign). Oracle's backlog (RPO $138B) indicates multi-year demand pipeline, reinforcing confidence in near-term growth.

• Cash Flow and Shareholder Returns: Oracle is a cash cow. Even in leaner years, FCF was above $8B; it's now trending $15B+ for FY25. Oracle's conversion of earnings to free cash is excellent over time (e.g. in FY2024 net $10.5B, FCF $11.8B - slightly higher because of non-cash amortization and good working capital management). This indicates high earnings quality. Oracle has deployed cash extremely shareholder-friendly: $100B buybacks and dividends. This has significantly reduced share count and boosted per-share metrics. It also signaled management's confidence (they wouldn't heavily leverage and buy shares if they thought Oracle's business was deteriorating). The downside is elevated debt which introduces some risk (especially if interest rates rise or if new acquisitions are needed - Oracle's debt capacity is somewhat constrained now). But Oracle's step to slow buybacks post-Cerner and prioritize debt reduction is a prudent pivot to maintain financial strength. The new dividend hike to $0.50/qtr further underlines Oracle's abundant cash and commitment to return it to investors.

• Balance Sheet Risk: Oracle's negative/low equity and high debt ratios might alarm a casual observer, but given Oracle's stable recurring revenue (over 70% of rev is recurring cloud/license support) and hefty cash generation, the leverage is manageable. Interest coverage ~4-5x is adequate. Oracle's plan to pay down ~$7B debt per year (which they did in FY2025) will, within a few years, bring debt to a more comfortable <3x EBITDA and reduce interest burden. Essentially, Oracle intentionally optimized its capital structure for cheap debt usage; as rates have risen, they're easing back on that leverage. Thus the risk of financial distress is minimal barring an unexpected collapse in demand (which seems unlikely given enterprise IT's stickiness and Oracle's unique position in databases). In worst-case scenario, Oracle could cut buybacks or dividend to preserve cash - an option they clearly have (they are discretionary outflows).

• Valuation & Market Expectations: Oracle's current valuation ratios (P/E ~30x non-GAAP EPS) show the market is pricing Oracle as a growth stock rather than a value stock now. That multiple is higher than peers like SAP (around 25x) or IBM (15x), reflecting expectation of superior growth. Considering Oracle's guided cloud growth and AI upside, the valuation can be justified if Oracle achieves sustained double-digit earnings growth. If growth falls back to low single-digits after a spurt, then the stock could be overpriced. But given backlog and product momentum, a period of above-average growth looks likely. Also, the market likely appreciates Oracle's increasing portion of subscription revenue (which merits higher multiples for reliability). With 77% of revenue now recurring (cloud + support), Oracle's earnings are more predictable than a decade ago (when license sales were lumpy). That lower risk plus growth could warrant a premium.

• Competitive Moat: The metrics indirectly confirm Oracle's moat - consistently high margins and ROIC mean Oracle can fend off competitors and maintain pricing (customers rarely rip out Oracle databases; they pay the support). However, flat revenue for many years indicated some moat erosion or at least difficulty expanding (cloud up, but on-prem license down, etc.). The new growth spurt hints Oracle found new ways to leverage its strengths (e.g. synergy of database + infrastructure, integrated cloud apps). If those strategies hold, Oracle's moat will extend into the cloud era. The large backlog shows customers are committing to Oracle long term (including new cloud customers in ERP, infrastructure deals). That is a bullish sign regarding Oracle's competitive positioning.

• Management Efficacy: The financial history depicts management adept at managing cycles. They didn't panic in low-growth years - instead, they doubled down on R&D ($8-9B/year consistently) and executed large buybacks at low prices (2015-2018). That capital allocation benefited shareholders massively when growth returned. The downside was increased debt, but as discussed, they are handling that. Management's forecasts (e.g. promising acceleration and delivering in FY2023-24) have been largely on target, which builds credibility. The big upcoming test is hitting that >40% cloud growth in FY2026 - if Safra Catz delivers that, the market will likely reward Oracle further.

Overall View: Oracle today looks financially strong and on an upswing. It's a mature company that has reignited growth via strategic moves, all while maintaining enviable profitability. The trade-offs are a levered balance sheet and a stock price that already reflects some optimism. But the metrics show a clear improvement trajectory: revenue climbing, margins recovering, cash flows at record levels. Oracle appears to be in the best financial shape it's been in years, aside from the high debt (which is being whittled down). If I had to summarize: Oracle has transitioned from a cash-rich, low-growth value stock to a cash-rich, moderate-growth compounder.

Investors should watch how much of the backlog translates to revenue (execution risk in cloud deployment), whether margins continue to improve (cloud scale vs cloud price competition), and that debt reduction stays a priority. As of now, the trends are favorable: net margins expanding, FCF margin recovering, and debt metrics improving quarter by quarter.

Given these metrics, I feel positively about Oracle's fundamentals. The company's entrenched products ensure resilience (we saw even in tough times like FY2020, revenue only dipped 1%). Now with new growth drivers, Oracle is poised for a period of potentially significant earnings expansion, which could further improve valuation ratios (bringing P/E down if E grows). If those growth plans falter, the high valuation could be a risk. But the numbers provide confidence that Oracle's reinvention is succeeding.

Trend Graphs of Key Metrics (10-Year Trends)#

To visualize Oracle's trends, below are line charts for select metrics over the past 10 years, accompanied by the historical data tables:

1. Market Price & Market Cap: The chart shows Oracle's share price and market capitalization climbing steadily after 2015, with a sharp acceleration from 2020 onwards. This reflects both stock appreciation and share count reduction. Oracle's market cap roughly tripled in the decade (from ~$140B to ~$470B).

Oracle's stock price (yellow, left axis) and market capitalization (orange, right axis) over FY2015-FY2024. The stock price nearly quintupled from the mid-$30s to mid-$160s, while aggressive share buybacks also contributed to market cap growth.

2. Revenue vs Net Income: Over the decade, revenue (yellow line) was flat to modestly up until a recent jump, whereas net income (orange line) had large volatility due to one-time items. The net income dips in 2018 and 2022 are evident, as is the surge in 2021 and recovery by 2024. Net income has not grown nearly as much as revenue because of increased expenses and amortization. However, one can see net income trending upward again after 2022.

Oracle's total revenue (yellow) and net income (orange) from FY2015 to FY2024. Revenue stayed in the ~$37-40B range for many years before rising to ~$53B in FY2024. Net income fluctuated significantly with a low in FY2018 (tax charge) and FY2022 (acquisition costs), then improved to $10.5B by FY2024.

3. Net Profit Margin & Free Cash Flow Margin: This chart illustrates Oracle's profitability in percentage terms. Net margin (yellow) was relatively stable ~24-26% mid-decade, plummeted in FY2018 and FY2022 (as discussed), and is ~20% in FY2024 - somewhat below earlier levels but rising. Free cash flow margin (orange) was very high (~34%) in earlier years, took a huge hit in FY2022 (dropping to ~12%) when capex spiked, but recovered to ~22% in FY2024. The dip in FCF margin shows Oracle's heavy cloud investment phase, while the rebound indicates those investments are starting to pay off.

Oracle's net profit margin (yellow) and free cash flow margin (orange) trends. Net margin dropped sharply in FY2018 and FY2022 due to extraordinary expenses, but excluding those, Oracle maintains ~25-30% margins. Free cash flow margin likewise fell in FY2022 (cloud CapEx surge) to ~12%, then recovered to ~22% in FY2024 as CapEx normalized.

4. Return on Invested Capital (ROIC): Oracle's ROIC (not shown graphically above due to complexity) has stayed around the mid-teens. It dipped in FY2018 (one-time tax charge affected NOPAT) and FY2022 (lower earnings, higher capital from Cerner), but the long-run level ~15-20% suggests Oracle's core business generates strong returns. FY2024 ROIC ~17.6% is a good sign that new investments are value-accretive.

5. Owner's Earnings (Free Cash Flow): The free cash flow graph (not embedded separately due to redundancy with margins) would show a plateau around $12-13B, a dive to $5B in FY2022, then a rise to $11.8B in FY2024, and based on FY2025 reported, heading even higher. This U-shaped FCF trend captures Oracle's transition investment and re-emergence.

6. Shareholders' Equity: Oracle's equity graph would decline steadily from $49B in 2015 to negative in 2022, then tick up in 2024 to $9B. This illustrates how Oracle returned accumulated equity to shareholders (via buybacks and dividends) - effectively moving value from the balance sheet to shareholders' hands.

7. Valuation Ratios (P/E & P/B): These ratios soared as stock price rose and equity shrank. P/E ranged ~14x to 19x for years then jumped to 30-45x recently. P/B became not meaningful once equity became very low; earlier it was ~3x then ballooned to 50x+ by 2024. The trend reflects multiple expansion and diminishing book value.

8. Leverage Ratios (Debt/Equity & Debt/Assets): Debt/Equity climbed off the chart after 2018 (infinite when equity negative). Debt/Assets went from ~35% to ~70-80% as discussed. A graph would show a steady increase in leverage, peaking in 2022, with a slight downtick in 2024 as equity turned positive and assets rose.

Summary: Oracle's trends highlight a pivot from a stagnant but highly profitable legacy state to a growth-oriented, cloud-driven enterprise. The financial metrics show near-term pressure when Oracle made big moves (affecting margins and cash flow) but also demonstrate Oracle's resilience and resurgence after these moves, evident by improving margins and skyrocketing cash flows post-investment. As an analyst, one would say Oracle's past challenges are largely overcome, and key metrics are now trending favorably (especially revenue and FCF growth). The trade-off is a higher debt load from funding that transition, which is being managed down.

Discounted Cash Flow (DCF) Analysis of Oracle's Stock#

To evaluate Oracle's valuation using a conservative DCF model, we perform two scenarios: one using a "low-growth" assumption (reflecting the lowest growth Oracle experienced in the past decade) and another using an "average growth" assumption (reflecting Oracle's historical average growth). We incorporate a fixed discount rate of 10% (typical Buffett hurdle for large stable companies) and ensure the terminal growth rate is kept below 3% (to be conservative and below GDP growth). We also examine the margin of safety and implied expected return given the current stock price.

Shares Outstanding: Oracle currently has ~2.82 billion shares. We'll use this for per-share value calculations.

Scenario A - Low Growth (Conservative Case):

• Assumptions: Free cash flow grows at a very modest 2% per year for the next 5 years (below nominal GDP, reflecting a pessimistic case of near stagnation). Terminal growth is set to 1.5% (essentially just inflation, below 3%). Discount rate = 10%.

• Rationale: This scenario might represent Oracle facing stiff competition and only eking out slight growth (perhaps support revenue erodes faster, cloud growth slows dramatically). Essentially, Oracle's cash flows barely grow in real terms.

• Calculations: Starting FCF (Year 0, FY2024) = $11.8B. > Year 1 FCF = $12.0B, Year 2 = $12.2B, … Year 5 = $13.0B. Sum of present values of Years 1-5 FCF ≈ $47.8B (as detailed earlier). > Terminal value in Year 5 = Year6 FCF / (10% - 1.5%) = $13.2B / 8.5% ≈ $155.3B. Present value of terminal = $155.3B / (1.10)^5 ≈ $96.5B. > Total DCF value (enterprise) = $47.8B + $96.5B = $144.3B. Subtract net debt ($92B in mid-2025, but at FY24 it was ~$100B debt - $8.4B cash = $91.6B net). Using $92B net debt, equity value = $52.3B. Divide by 2.82B shares = $18.54 per share. > Wait, this result ($18.5) is even lower than earlier rough calc ($35.9) - likely because I used mid-2025 net debt ($92B) which is fine, but I double subtracted something. Actually, let's carefully use FY24 net debt: $100.13B - $8.44B = $91.69B. Equity = $144.3B - $91.7B = $52.6B, /2.82B = $18.65/share. That seems too low - I suspect the sum of PV I had ($47.8B) might have been mis-estimated. Re-evaluate PV of 5-year flows: > More precisely: > Year1 (2025) FCF = $12.04B, PV1 = $10.94B; > Year2 FCF = $12.28B, PV2 = $10.16B; > Year3 = $12.52B, PV3 = $9.46B; > Year4 = $12.77B, PV4 = $8.83B; > Year5 = $13.03B, PV5 = $8.27B. > Sum PVs = $47.66B (I used that earlier, okay). Terminal value Year5 = $13.03B*(1.015)/(0.10-0.015) = $13.23B/8.5% = $155.7B, PV term = $155.7/(1.10)^5 = $96.63B. Sum = $144.3B enterprise. > Yes, equity = $144.3 - $91.7 = $52.6B, per share ~ $18.6.

This scenario yields an intrinsic value of roughly $18-19 per share. That's extremely low - likely too pessimistic/unrealistic since Oracle's current FCF yield (~2.5%) suggests the market expects more growth or lower discount.

This indicates that if Oracle only grows 2% long-term, a value investor demanding 10% return would value it under $20. That's about an 83% drop from current price - an enormous margin of safety gap. Clearly the market (and we as analysts) do not expect Oracle to stagnate that badly.

Nonetheless, under this dismal scenario, there's huge downside if those assumptions held.

Margin of Safety: If one required 30% margin of safety on that $18.6 intrinsic (which is extremely conservative already), they'd only pay ~$13 per share. Oracle hasn't been that low since early 2000s, showing that our scenario A is beyond conservative - essentially pricing in catastrophic decline relative to reality.

Scenario B - Average Growth (Likely Base Case):

• Assumptions: Free cash flow grows at an 6% CAGR for the next 5 years (consistent with Oracle's current organic cloud growth environment, but tempered). Terminal growth = 2% (assuming Oracle can grow at inflation in perpetuity with cloud maintenance). Discount = 10%.

• Rationale: Oracle has guided to double-digit rev growth next couple years - we use 6% FCF growth to average out perhaps faster growth initially then slower later. This might correspond to, say, revenue ~8% CAGR and FCF margin creeping up, resulting in ~6% FCF growth.

• Calculations: Starting FCF = $11.8B. Year1 $12.5B, Year2 $13.25B, Year3 $14.05B, Year4 $14.90B, Year5 $15.80B. > PVs: > Y1 PV = $11.36B, > Y2 = $10.97B, > Y3 = $10.58B, > Y4 = $10.18B, > Y5 = $9.78B. > Sum PV5 = $52.9B. > Terminal Year5 = $15.80B*(1.02)/(0.10-0.02) = $16.12B/0.08 = $201.5B. PV term = $201.5/(1.10)^5 = $125.0B. > Enterprise value = $52.9 + $125.0 = $177.9B. Equity = $177.9 - $91.7 = $86.2B. Per share = $30.53.

This intrinsic value is around $30.5 per share under the moderate 6% growth scenario. That's still about 71% below current price $105. It indicates that even with decent growth, at a strict 10% discount, Oracle isn't worth nearly what it trades for.

What margin of safety is in the current price? Actually, reverse perspective: current price is $105 vs scenario B intrinsic $30.5 - the price is 3.4x the intrinsic implying no margin of safety, more like margin of danger by that view. However, scenario B might still be too conservative because Oracle's first few years might grow well above 6%.

Let's try a scenario aligning more with Oracle's own outlook: say 10% growth for 5 years (some years higher, some lower), then 2.5% terminal, discount 10%. This would be more optimistic but still within reason:

Scenario C - High Growth (Upside Case):

• 10% FCF growth for 5 years, then 2.5% terminal, 10% discount.

Year5 FCF ~ $11.8*(1.1^5) = $19.0B. PV of first 5 flows (calc quickly): Year1 $12.98B PV = $11.80B, Year2 $14.28B PV = $11.80/(1.10)?? Let's do systematically: Year1 = 12.98 PV=11.80; Y2 = 14.28 PV=11.81; Y3 = 15.71 PV=11.77; Y4 = 17.28 PV=11.68; Y5 = 19.01 PV=11.54. Sum PV5 ~ $58.6B. Terminal Year5 = $19.01B*(1.025)/(0.10-0.025) = $19.48B/7.5% = $259.7B, PV term = $259.7/(1.10^5) = $161.2B. EV = 58.6+161.2 = $219.8B. Equity = $219.8 - $91.7 = $128.1B. Per share = $45.4.

So even with an aggressive 10% growth for 5 years, intrinsic is ~$45. That's closer to current price but still less than half. This reveals that the main issue is the 10% discount rate assumption. The market is clearly using a lower implied discount, maybe around 7% as we earlier estimated, given yields environment and perhaps viewing Oracle as safer.

Implied Expected Return (Internal Rate of Return): We can solve: what discount rate makes scenario B's DCF equal the current $105? We can adjust discount down until DCF equity = $105 * 2.82B = $296.1B equity + $91.7B net debt = $387.8B EV.

Using scenario B cash flows (6% growth 5 years, 2% term): We want PV flows + PV term at rate r = $387.8B.

We got at 10%: $177.9B EV. At 8% earlier quick calculation EV was $237.7B (with slight different flows I found $237B earlier). So at 7% maybe EV gets to ~$300B+. Let's try 7%:

• PV flows (7%): > Year1 $12.5B PV= $11.68B, > Y2 $13.25B PV= $11.54B, > Y3 $14.05B PV= $11.41B, > Y4 $14.90B PV= $11.27B, > Y5 $15.80B PV= $11.14B. > Sum PV5 = $57.0B.

• Terminal (Year5) at 7%: $15.80B*(1.02)/(0.07-0.02) = $16.12B/5% = $322.4B, PV term = $322.4/(1.07^5) = $229.5B.

• EV = $57.0 + $229.5 = $286.5B. Equity = $194.8B. Per share = $69.1.

At 7%, intrinsic ~$69. So not enough. At 6% discount: We did earlier scenario C at 6% got ~$112 per share for something like moderate-high growth. But let's do scenario B at 6%:

• PV flows (6%): > Year1 PV = $11.80B (since 12.5/1.06), > Y2 $13.25/1.06^2 = $11.78B, > Y3 $14.05/1.06^3 = $11.73B, > Y4 $14.90/1.06^4 = $11.65B, > Y5 $15.80/1.06^5 = $11.55B. > Sum = $58.5B.

• Terminal at 6%: $15.80B*1.02/(0.06-0.02) = $16.12/4% = $403B, PV term = $403/1.06^5 = $301.8B.

• EV = 58.5 + 301.8 = $360.3B, equity = $268.6B, per share = $95.2.

At ~5.5% it might equate: Say 5.5% discount: We can guess maybe around $105 intrinsic.

So indeed, the expected return implied by current price is around 5.5-6% if we assume 6% cash flow growth long-term. If we assume faster growth, then expected return might be higher.

Alternatively, we find IRR for scenario C (10% growth 5 yrs, 2.5% term) by equating $296B equity target: At 8%, scenario C gave EV $300B, equity ~$208B, share ~$73 (still below 105). At 6%, scenario C gave share $112, a tad above $105, so IRR maybe ~6.3%. At 6.5% discount: We can surmise it might exactly equal $105. So expected return ~6.5% with those robust growth assumptions.

Thus, realistically, investors might be expecting ~7% returns if Oracle hits moderately strong growth, or ~5-6% if growth disappoints (closer to scenario B). Considering Oracle's low risk profile, some investors might accept 7% expected return as okay.

Warren Buffett's perspective: He typically wants a 10% expected return or more, and a big margin of safety. By that criterion, Oracle at $105 is far too expensive for him, which is consistent with him selling at $50 in 2018 (and not rebuying even when it was around $45 in early 2019). Possibly he re-evaluated the moat or didn't see enough safety.

Conclusion of DCF: Oracle's DCF valuations under conservative discount rates are below the market price, implying the stock's valuation is banking on lower discount (i.e. safe earnings akin to a bond) or higher growth. If one insists on a 10% discount (Buffett style), there is no margin of safety at all at $105 - in fact the stock would look significantly overvalued.

However, if one is comfortable with a 6-7% discount (which might be justifiable in a low-rate environment for a stable company), then Oracle's price can be rationalized especially if growth exceeds our modest projections in the near term (which looks likely given the backlog and AI factor).

Financial Disclaimer: This analysis is educational and based on publicly available information and reasonable assumptions. Actual outcomes could differ due to unforeseeable changes in Oracle's business or the economy. All numerical estimates above (intrinsic values, IRRs) are illustrative and not precise predictions. They should not be taken as investment advice. Investors should conduct their own due diligence or consult a financial advisor, and consider their risk tolerance. Past financial performance does not guarantee future results.